ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
In what the partners are calling an industry first, chemistry undergraduates at England’s University of Nottingham will research drugs for GlaxoSmithKline. The collaboration, launching this month, will see 12 Nottingham students research, synthesize, and test kinase inhibitors as potential treatments for asthma. The students will work with a GSK medicinal chemistry mentor as well as university chemists. Dave Allen, head of chemistry at GSK, says the collaboration will ensure his company’s continued access to high-caliber entry-level chemists.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X